Please login to the form below

Not currently logged in
Email:
Password:

Anoro Ellipta

This page shows the latest Anoro Ellipta news and features for those working in and with pharma, biotech and healthcare.

Sovaldi pushes Gilead to the top of US pharma list

Sovaldi pushes Gilead to the top of US pharma list

The London-based firm has also failed to increase market share for its next-gen versions of Advair - namely Breo, Ellipta and Anoro Ellipta - which had combined sales last year of

Latest news

  • GSK's Anoro first LAMA/LABA approved for COPD in US GSK's Anoro first LAMA/LABA approved for COPD in US

    GSK's Anoro first LAMA/LABA approved for COPD in US. Important step towards eventually replacing Seretide/Advair sales. ... GlaxoSmithKline's (GSK) chronic obstructive pulmonary disease (COPD) portfolio received a significant boost yesterday with the US

  • GSK’s COPD drug Anoro under review in US GSK’s COPD drug Anoro under review in US

    GSK’ s COPD drug Anoro under review in US. FDA accepts new drug application for the LAMA/LABA combination. ... GlaxoSmithKline's (GSK) investigational respiratory treatment Anoro is under review by the FDA after the US regulator accepted its new drug

More from news
Approximately 1 fully matching, plus 2 partially matching documents found.

Latest appointments

  • Theravance hires BMS veteran Pasqualone Theravance hires BMS veteran Pasqualone

    Pasqualone joins Theravance as the company at a crucial time as its development deals with GlaxoSmithKline bears fruit with US approval of respiratory treatment Anoro Ellipta.

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
OUTiCO

Providing an exceptional outsourcing service to the Pharma & Healthcare industries. We offer a sustainable approach and drive sales outcomes...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics